Literature DB >> 21534651

Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.

Andrew T Gloster1, Hans-Ulrich Wittchen, Franziska Einsle, Thomas Lang, Sylvia Helbig-Lang, Thomas Fydrich, Lydia Fehm, Alfons O Hamm, Jan Richter, Georg W Alpers, George W Alpers, Alexander L Gerlach, Andreas Ströhle, Tilo Kircher, Jürgen Deckert, Peter Zwanzger, Michael Höfler, Volker Arolt.   

Abstract

OBJECTIVE: Cognitive-behavioral therapy (CBT) is a first-line treatment for panic disorder with agoraphobia (PD/AG). Nevertheless, an understanding of its mechanisms and particularly the role of therapist-guided exposure is lacking. This study was aimed to evaluate whether therapist-guided exposure in situ is associated with more pervasive and long-lasting effects than therapist-prescribed exposure in situ.
METHOD: A multicenter randomized controlled trial, in which 369 PD/AG patients were treated and followed up for 6 months. Patients were randomized to 2 manual-based variants of CBT (T+/T-) or a wait-list control group (WL; n = 68) and were treated twice weekly for 12 sessions. CBT variants were identical in content, structure, and length, except for implementation of exposure in situ: In the T+ variant (n = 163), therapists planned and supervised exposure in situ exercises outside the therapy room; in the T- group (n = 138), therapists planned and discussed patients' in situ exposure exercises but did not accompany them. Primary outcome measures were (a) Hamilton Anxiety Scale, (b) Clinical Global Impression, (c) number of panic attacks, and (d) agoraphobic avoidance (Mobility Inventory).
RESULTS: For T+ and T- compared with WL, all outcome measures improved significantly with large effect sizes from baseline to post (range = -0.5 to -2.5) and from post to follow-up (range = -0.02 to -1.0). T+ improved more than T- on the Clinical Global Impression and Mobility Inventory at post and follow-up and had greater reduction in panic attacks during the follow-up period. Reduction in agoraphobic avoidance accelerated after exposure was introduced. A dose-response relation was found for Time × Frequency of Exposure and reduction in agoraphobic avoidance.
CONCLUSIONS: Therapist-guided exposure is more effective for agoraphobic avoidance, overall functioning, and panic attacks in the follow-up period than is CBT without therapist-guided exposure. Therapist-guided exposure promotes additional therapeutic improvement--possibly mediated by increased physical engagement in feared situations--beyond the effects of a CBT treatment in which exposure is simply instructed. (PsycINFO Database Record (c) 2011 APA, all rights reserved).

Entities:  

Mesh:

Year:  2011        PMID: 21534651     DOI: 10.1037/a0023584

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  30 in total

1.  Does prior traumatization affect the treatment outcome of CBT for panic disorder? The potential role of the MAOA gene and depression symptoms.

Authors:  Sebastian Trautmann; Jan Richter; Markus Muehlhan; Michael Höfler; Hans-Ulrich Wittchen; Katharina Domschke; Andreas Ströhle; Alfons O Hamm; Heike Weber; Tilo Kircher; Volker Arolt; Alexander L Gerlach; Georg W Alpers; Thomas Fydrich; Thomas Lang; Andreas Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-07-15       Impact factor: 5.270

Review 2.  [Guideline-oriented inpatient psychiatric psychotherapeutic/psychosomatic treatment of anxiety disorders : How many personnel are need?].

Authors:  B Bandelow; U Lueken; J Wolff; F Godemann; C Wolff-Menzler; J Deckert; A Ströhle; M Beutel; J Wiltink; K Domschke; M Berger
Journal:  Nervenarzt       Date:  2016-03       Impact factor: 1.214

3.  5HTT is associated with the phenotype psychological flexibility: results from a randomized clinical trial.

Authors:  Andrew T Gloster; Alexander L Gerlach; Alfons Hamm; Michael Höfler; Georg W Alpers; Tilo Kircher; Andreas Ströhle; Thomas Lang; Hans-Ulrich Wittchen; Jürgen Deckert; Andreas Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-01-15       Impact factor: 5.270

Review 4.  The German guidelines for the treatment of anxiety disorders.

Authors:  Borwin Bandelow; Thomas Lichte; Sebastian Rudolf; Jörg Wiltink; Manfred E Beutel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-18       Impact factor: 5.270

5.  Reconciling RDoC and DSM approaches in clinical psychophysiology and neuroscience.

Authors:  Lisa M McTeague
Journal:  Psychophysiology       Date:  2016-03       Impact factor: 4.016

Review 6.  The diagnosis of and treatment recommendations for anxiety disorders.

Authors:  Borwin Bandelow; Thomas Lichte; Sebastian Rudolf; Jörg Wiltink; Manfred E Beutel
Journal:  Dtsch Arztebl Int       Date:  2014-07-07       Impact factor: 5.594

7.  The Diagnosis and Treatment of Anxiety Disorders.

Authors:  Andreas Ströhle; Jochen Gensichen; Katharina Domschke
Journal:  Dtsch Arztebl Int       Date:  2018-09-14       Impact factor: 5.594

8.  MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy.

Authors:  A Reif; J Richter; B Straube; M Höfler; U Lueken; A T Gloster; H Weber; K Domschke; L Fehm; A Ströhle; A Jansen; A Gerlach; M Pyka; I Reinhardt; C Konrad; A Wittmann; B Pfleiderer; G W Alpers; P Pauli; T Lang; V Arolt; H-U Wittchen; A Hamm; T Kircher; J Deckert
Journal:  Mol Psychiatry       Date:  2013-01-15       Impact factor: 15.992

9.  Therapygenetics: anterior cingulate cortex-amygdala coupling is associated with 5-HTTLPR and treatment response in panic disorder with agoraphobia.

Authors:  Ulrike Lueken; Benjamin Straube; Hans-Ulrich Wittchen; Carsten Konrad; Andreas Ströhle; André Wittmann; Bettina Pfleiderer; Volker Arolt; Tilo Kircher; Jürgen Deckert; Andreas Reif
Journal:  J Neural Transm (Vienna)       Date:  2014-09-16       Impact factor: 3.575

Review 10.  Advancing psychotherapy and evidence-based psychological interventions.

Authors:  Paul M G Emmelkamp; Daniel David; Tom Beckers; Peter Muris; Pim Cuijpers; Wolfgang Lutz; Gerhard Andersson; Ricardo Araya; Rosa M Banos Rivera; Michael Barkham; Matthias Berking; Thomas Berger; Christina Botella; Per Carlbring; Francesc Colom; Cecilia Essau; Dirk Hermans; Stefan G Hofmann; Susanne Knappe; Thomas H Ollendick; Filip Raes; Winfried Rief; Heleen Riper; Saskia Van Der Oord; Bram Vervliet
Journal:  Int J Methods Psychiatr Res       Date:  2014-01       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.